Business Description
CTT Pharmaceutical Holdings Inc
NAICS : 456110
SIC : 2834
ISIN : US12651E1064
Total Employee Number:
2Description
CTT Pharmaceutical Holdings Inc specializes in drug delivery systems technology within the pharmaceutical industry. Its focus is on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The company's technology platform includes the development of oral delivery thin wafers to deliver treatment as an alternative to smoking and ingestion. This technology platform target both the human and veterinarian(pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in majorly markets such as pain management and smoking cessation. The Oral Thin Film formulation is protected by patents in the USA, Canada, Europe and many other countries across the world.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 80.6 | |||||
3-Year FCF Growth Rate | 71.7 | |||||
3-Year Book Growth Rate | -76.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.92 | |||||
9-Day RSI | 23.67 | |||||
14-Day RSI | 29.75 | |||||
3-1 Month Momentum % | -8.33 | |||||
6-1 Month Momentum % | -15.62 | |||||
12-1 Month Momentum % | 38.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -44.5 | |||||
Shareholder Yield % | -0.94 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -288.46 | |||||
ROA % | -190.09 | |||||
ROIC % | -185.23 | |||||
ROCE % | -284.97 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -18.12 | |||||
EV-to-EBITDA | -18.81 | |||||
EV-to-FCF | -55.72 | |||||
Price-to-Projected-FCF | 5 | |||||
Earnings Yield (Greenblatt) % | -5.52 | |||||
FCF Yield % | -1.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CTTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CTT Pharmaceutical Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | -0.0556 | ||
| 3-Year Sharpe Ratio | 0.79 | ||
| 3-Year Sortino Ratio | 3.11 | ||
| Volatility % | 52.03 | ||
| 14-Day RSI | 29.75 | ||
| 14-Day ATR ($) | 0.005737 | ||
| 20-Day SMA ($) | 0.059801 | ||
| 12-1 Month Momentum % | 38.51 | ||
| 52-Week Range ($) | 0.035 - 0.1 | ||
| Shares Outstanding (Mil) | 58.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CTT Pharmaceutical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CTT Pharmaceutical Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2015-08-28 | 0.50 (-9.91%) | ||
| 0.05:1 Stock Split | 2011-07-26 | 8.00 (+0.00%) |
Show
Entries
CTT Pharmaceutical Holdings Inc Frequently Asked Questions
What is CTT Pharmaceutical Holdings Inc(CTTH)'s stock price today?
The current price of CTTH is $0.05. The 52 week high of CTTH is $0.10 and 52 week low is $0.04.
When is next earnings date of CTT Pharmaceutical Holdings Inc(CTTH)?
The next earnings date of CTT Pharmaceutical Holdings Inc(CTTH) is .
Does CTT Pharmaceutical Holdings Inc(CTTH) pay dividends? If so, how much?
CTT Pharmaceutical Holdings Inc(CTTH) does not pay dividend.
Guru Commentaries on OTCPK:CTTH
Greenwood Investors
Bullish
2026 Q2
What the manager wrote
Our interest in CTT started by being highly attracted to the value unlock and simplification that a bank sale or spin-off would bring. While patiently waiting for that environment to change, there was ample work to do in creating an e-commerce flywheel off the back of CTT’s low-cost and ultra-dense mail network. The company has been able to rebuild earnings beyond historical highs — driven nearly entirely by the secular growth in e-commerce. Despite some e-commerce volatility, we think the company is more attractive today than ever: because the accretion factor when considering a partial or full monetization of the bank is transformational. This next year will break another record for being the most transformational one in CTT’s 506-year history.
Press Release
Articles on CTT Pharmaceutical Holdings Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers